From autoantibody research to standardized diagnostic assays in the management of human diseases - Report of the 12th Dresden Symposium on Autoantibodies

Lupus

Volumn 25, Issue 8, 2016, Pages 787-796

  Conrad, K ^a   Andrade, L E C ^b,c   Chan, E K L ^d   Mahler, M ^e   Meroni, P L ^f   Pruijn, G J M ^g   Steiner, G ^h   Shoenfeld, Y ^i,j  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Fleury   (Brazil)

^d UNIVERSITY OF FLORIDA   (United States)

^e INOVA DIAGNOSTICS INC   (United States)

^f UNIVERSITY OF MILAN   (Italy)

^g RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^h MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁱ TEL AVIV UNIVERSITY   (Israel)

^j SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

ANA; autoantibodies; autoimmune diseases; autoimmunity; diagnostics; standardization

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ALGORITHM; ARTICLE; ASSAY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; CONSENSUS; DIAGNOSTIC TEST; GASTROINTESTINAL DISEASE; HUMAN; LIVER DISEASE; MEDICAL RESEARCH; MYOSITIS; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STANDARDIZATION; SYMPOSIUM; SYSTEMIC SCLEROSIS; AUTOIMMUNE DISEASES; BLOOD; EARLY DIAGNOSIS; GERMANY; ORGANIZATION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CONGRESSES AS TOPIC; EARLY DIAGNOSIS; GERMANY; HUMANS;

EID: 84973351134     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316644337     Document Type: Article

References (43)

1. Chan EKL, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015. Front Immunol 2015; 6:. DOI: 10.3389/fimmu.2015.00412.
2. Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, et al. International Consensus on ANA Patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Autoimmun Highlights 2016. DOI: 10.1007/s13317-016-0075-0.
3. Chan EKL, Damoiseaux J, de Melo Cruvinel W, et al. Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015. Lupus 2016. this issue.
4. Conrad K, Andrade LEC, Chan EKL, Pruijn GJM, Steiner G, Shoenfeld Y (eds). From Autoantibody Research to Standardized Diagnostic Assays in the Management of Human Diseases, Report on the 12th Dresden Symposium on Autoantibodies. Lengerich, Germany: Pabst Science Publishers, 2015.
5. Perricone C, Versini M, Ben-Ami D, et al. Smoke and autoimmunity: the fire behind the disease. Autoimmun Rev 2016; 15: 354-374.
6. Versini M, Aljadeff G, Jeandel P-Y, Shoenfeld Y,. Obesity: an additional piece in the mosaic of autoimmunity. IMAJ 2014; 16: 619-621.
7. Lerner A, Matthias T,. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 2015; 14: 479-489.
8. Bogdanos DP, Smyk DS, Rigopoulou EI, Sakkas LI, Shoenfeld Y,. Infectomics and autoinfectomics: a tool to study infectious-induced autoimmunity. Lupus 2015; 24: 364-373.
9. Meroni PL,. Anti-beta2 GPI epitope specificity: from experimental models to diagnostic tool. Lupus 2016. this issue.
10. Pengo V, Ruffatti A, Tonello M, et al. Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk. J Thromb Haemostasis 2015; 13: 782-787.
11. Mahler M, Norman GL, Meroni PL, Khamashta M,. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev 2012; 12: 313-317.
12. Fickentscher C, Magorivska I, Janko C, et al. The pathogenicity of anti-beta2GP1-IgG autoantibodies depends on Fc glycosylation. J Immunol Res 2015. DOI: org/10.1155/2015/638129.
13. Herrmann M,. Importance of glycan accessibility at the Fc part of IgG for patients with rheumatic diseases. Lupus 2016. this issue.
14. Calise SJ, Keppeke GD, Andrade LE, Chan EKL,. Anti-rods/rings: a human model of drug-induced autoantibody generation. Front Immunol 2015; 6:. DOI: 10.3389/fimmu.2015.00041.
15. Carcamo W, Ceribelli A, Calise SJ, et al. Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients. J Clin Immunol 2013; 33: 420-426.
16. Yang Z, Chevolot Y, Géhin T, et al. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera. Biosens Bioelectron 2013; 40: 385-392.
17. Murphy MA, O'Connell DJ, O'Kane SL, et al. Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays. J Proteomics 2012; 75: 4668-4675.
18. Pereira KM, Dellavance A, Andrade LE,. The challenge of identification of autoantibodies specific to systemic autoimmune rheumatic diseases in high throughput operation: proposal of reliable and feasible strategies. Clin Chim Acta 2014; 437: 203-210.
19. Chan EK, Fritzler MJ, Wiik A, et al. The IUIS/WHO/AF/CDC committee for the standardization of autoantibodies in rheumatic and related diseases-Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007; 6: 577-580.
20. Shoenfeld Y, Cervera R, Haass M, et al. EASI-The European Autoimmunity Standardisation Initiative: a new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann N Y Acad Sci 2007; 1109: 138-144.
21. Meroni PL, Biggioggero M, Pierangeli SS, Sheldon J, Zegers I, Borghi MO,. Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nat Rev Rheumatol 2014; 10: 35-43.
22. Sheldon J, Dellavance A,. Strategies for building reference standards for autoantibodies. Front Immunol 2015; 6:. DOI: 10.3389/fimmu.2015.00194.
23. Mahler M, Meroni PL, Bossuyt X, Fritzler MJ,. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res 2014. DOI: 10.1155/2014/315179.
24. Tan EM, Smolen JS, McDougal JS, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 2002; 29: 68-74.
25. Fritzler MJ, Wiik A, Tan EM, et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol 2003; 30: 2374-2381.
26. Satoh M, Tanaka S, Chan EK,. The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases. Front Immunol 2015; 6:. DOI: 10.3389/fimmu.2015.00181.
27. Williams AJK, Lampasona V, Schlosser M, et al. Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes. Diabetes 2015; 64: 3239-3246.
28. Damoiseaux J, Agmon-Levin N, Van Blerk M, et al. From ANA screening to antigen specificity: an EASI survey on the daily practice in European countries. Clin Exp Rheumatol 2014; 32: 539-546.
29. Agmon-Levin N, Damoiseaux J, Shoenfeld Y,. Comment on: 'Detection of antinuclear antibodies: added-value of solid phase assay?' by Bossuyt and Fieuws. Ann Rheum Dis 2014; 73: e11-e11.
30. Tozzoli R, Antico A, Porcelli B, Bassetti D,. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlights 2012; 3: 59-65.
31. Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A,. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med 2014; 12: 38-38.
32. Budde P, Zucht HD, Vordenbäumen S, et al. Multiparameteric detection of autoantibodies in SLE. Lupus 2016. this issue.
33. Roggenbuck D, Somma V, Schierack P, Borghi MO, Meroni PL,. Autoantibody profiling in APS. Lupus 2014; 23: 1262-1264.
34. Scholz J, Grossmann K, Knütter I, et al. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing. Clin Chem Lab Med 2015; 53: 1991-2002.
35. + ATPase is an autoantibody target in paraneoplastic neurologic syndrome. Neurology 2015; 84: 1673-1679.
36. Nakashima R, Hosono Y, Mimori T,. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 2016. this issue.
37. Höftberger R,. Neuroimmunology: an expanding frontier in autoimmunity. Front Immunol 2015; 6:. DOI: 10.3389/fimmu.2015.00206.
38. Cantagrel A, Degboé Y,. New autoantibodies associated with rheumatoid arthritis recognize post-translationally modified self-proteins. Joint Bone Spine 2016; 83: 11-17.
39. Shi J, van Veelen PA, Mahler M, et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev 2014; 13: 225-230.
40. Basu A, Sanchez TW, Casiano CA,. DFS70/LEDGFp75: an enigmatic autoantigen at the interface between autoimmunity, AIDS, and cancer. Front Immunol 2015; 6:. DOI: 10.3389/fimmu.2015.00116.
41. Conrad K, Röber N, Rudolph S, Mahler M,. DFS70 antibodies-biomarkers for the exclusion of ANA-associated autoimmune rheumatic diseases. J Lab Med 2015. DOI: 10.1515/labmed-2015-0040.
42. Mahler M, Hanly JG, Fritzler J,. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 2012; 11: 642-645.
43. Mahler M, Meroni PL, Andrade LE, et al. Towards better understanding of the clinical association of anti-DFS70 autoantibodies. Autoimmun Rev 2016; 15: 198-201.